BTIG initiated coverage on Oncternal Therapeutics with a new price target
$ONCT
Biotechnology: Pharmaceutical Preparations
Health Care
BTIG initiated coverage of Oncternal Therapeutics with a rating of Buy and set a new price target of $5.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 2/24/2022 | $5.00 | Buy | BTIG |
| 2/24/2022 | $50.00 | Buy | BTIG |